These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 39014081)

  • 1. Chromatin remodellers as therapeutic targets.
    Malone HA; Roberts CWM
    Nat Rev Drug Discov; 2024 Sep; 23(9):661-681. PubMed ID: 39014081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploiting vulnerabilities of SWI/SNF chromatin remodelling complexes for cancer therapy.
    Wanior M; Krämer A; Knapp S; Joerger AC
    Oncogene; 2021 May; 40(21):3637-3654. PubMed ID: 33941852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BAFfling pathologies: Alterations of BAF complexes in cancer.
    Arnaud O; Le Loarer F; Tirode F
    Cancer Lett; 2018 Apr; 419():266-279. PubMed ID: 29374542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the role of SWI/SNF complexes in tumours.
    Li Z; Zhao J; Tang Y
    J Cell Mol Med; 2023 Apr; 27(8):1023-1031. PubMed ID: 36883311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SWI/SNF chromatin remodeling and human malignancies.
    Masliah-Planchon J; Bièche I; Guinebretière JM; Bourdeaut F; Delattre O
    Annu Rev Pathol; 2015; 10():145-71. PubMed ID: 25387058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathways: SWI/SNF (BAF) complexes are frequently mutated in cancer--mechanisms and potential therapeutic insights.
    Wang X; Haswell JR; Roberts CW
    Clin Cancer Res; 2014 Jan; 20(1):21-7. PubMed ID: 24122795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SWI/SNF complexes and cancers.
    Wang L; Tang J
    Gene; 2023 Jun; 870():147420. PubMed ID: 37031881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SWI/SNF nucleosome remodellers and cancer.
    Wilson BG; Roberts CW
    Nat Rev Cancer; 2011 Jun; 11(7):481-92. PubMed ID: 21654818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PHF6 cooperates with SWI/SNF complexes to facilitate transcriptional progression.
    Mittal P; Myers JA; Carter RD; Radko-Juettner S; Malone HA; Rosikiewicz W; Robertson AN; Zhu Z; Narayanan IV; Hansen BS; Parrish M; Bhanu NV; Mobley RJ; Rehg JE; Xu B; Drosos Y; Pruett-Miller SM; Ljungman M; Garcia BA; Wu G; Partridge JF; Roberts CWM
    Nat Commun; 2024 Aug; 15(1):7303. PubMed ID: 39181868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the SWI/SNF chromatin remodeling complex in pancreatic ductal adenocarcinoma.
    Tsuda M; Fukuda A; Kawai M; Araki O; Seno H
    Cancer Sci; 2021 Feb; 112(2):490-497. PubMed ID: 33301642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SWI/SNF complex in cancer - biology, biomarkers and therapy.
    Mittal P; Roberts CWM
    Nat Rev Clin Oncol; 2020 Jul; 17(7):435-448. PubMed ID: 32303701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A New Way Forward in Cancer Drug Discovery: Inhibiting the SWI/SNF Chromatin Remodelling Complex.
    Zinzalla G
    Chembiochem; 2016 Apr; 17(8):677-82. PubMed ID: 26684344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vulnerabilities of mutant SWI/SNF complexes in cancer.
    Helming KC; Wang X; Roberts CWM
    Cancer Cell; 2014 Sep; 26(3):309-317. PubMed ID: 25203320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SWI/SNF chromatin remodelling complex is required for maintenance of lineage specific enhancers.
    Alver BH; Kim KH; Lu P; Wang X; Manchester HE; Wang W; Haswell JR; Park PJ; Roberts CW
    Nat Commun; 2017 Mar; 8():14648. PubMed ID: 28262751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploiting epigenetic vulnerabilities in solid tumors: Novel therapeutic opportunities in the treatment of SWI/SNF-defective cancers.
    Chabanon RM; Morel D; Postel-Vinay S
    Semin Cancer Biol; 2020 Apr; 61():180-198. PubMed ID: 31568814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SWI/SNF Complex: A Frequently Mutated Chromatin Remodeling Complex in Cancer.
    Nguyen VT; Tessema M; Weissman BE
    Cancer Treat Res; 2023; 190():211-244. PubMed ID: 38113003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remodeling the cancer epigenome: mutations in the SWI/SNF complex offer new therapeutic opportunities.
    Orlando KA; Nguyen V; Raab JR; Walhart T; Weissman BE
    Expert Rev Anticancer Ther; 2019 May; 19(5):375-391. PubMed ID: 30986130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diverse roles and interactions of the SWI/SNF chromatin remodeling complex revealed using global approaches.
    Euskirchen GM; Auerbach RK; Davidov E; Gianoulis TA; Zhong G; Rozowsky J; Bhardwaj N; Gerstein MB; Snyder M
    PLoS Genet; 2011 Mar; 7(3):e1002008. PubMed ID: 21408204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic lethal therapy based on targeting the vulnerability of SWI/SNF chromatin remodeling complex-deficient cancers.
    Sasaki M; Ogiwara H
    Cancer Sci; 2020 Mar; 111(3):774-782. PubMed ID: 31955490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammalian SWI/SNF Chromatin Remodeling Complexes: Emerging Mechanisms and Therapeutic Strategies.
    Centore RC; Sandoval GJ; Soares LMM; Kadoch C; Chan HM
    Trends Genet; 2020 Dec; 36(12):936-950. PubMed ID: 32873422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.